Latin America, Middle East and Africa Stroke Management Market Size to register a growth of 8.0% CAGR

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report LAMEA Stroke Management Market, published by KBV research, the LAMEA Stroke Management Market would witness market growth of 8.0% CAGR during the forecast period (2018 – 2024).

The Brazil market would dominate the LAMEA Ischemic Stroke Management Market by Country 2017, and would continue to be a dominant market till 2024; thereby, achieving a market value of $898.3 million by 2024, growing at a CAGR of 7.2 % during the forecast period. The Argentina market is expected to witness a CAGR of 7.2% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 4.3% during (2018 - 2024).

The Diagnostics market dominated the UAE Stroke Management Market by Type 2017, and would achieve a market value of $516.7 million by 2024, growing at a CAGR of 5.3 % during the forecast period. The Therapeutics market is expected to witness highest CAGR of 6.9% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/lamea-stroke-management-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

LAMEA Stroke Management Market Segmentation

By Type

  • Diagnostics
  • Computed Tomography Scan (CT Scan)
  • Magnetic Resonance Imaging (MRI)
  • Echocardiography
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Others
  • Therapeutics
  • Tissue Plasminogen Activator
  • Anticoagulant
  • Antiplatelet
  • Other Therapeutics Type

By Application                                  

  • Ischemic Stroke
  • Hemorrhagic Stroke

 By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • Siemens Aktiengesellschaft
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company

Unique Offerings from KBV Research

  • Exhaustive coverage  
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Stroke Management Market (2018-2024)

North America Stroke Management Market (2018-2024)

Europe Stroke Management Market (2018-2024)

Asia Pacific Stroke Management Market (2018-2024)

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.